Abeona Therapeutics Inc.
ABEO
$5.39
-$0.02-0.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -296.43% | -104.74% | 1,004.76% | -29.44% | 69.30% |
| Total Depreciation and Amortization | 22.97% | 15.63% | -5.77% | 5.03% | 7.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,709.01% | 100.08% | -3,724.69% | 10.46% | -124.05% |
| Change in Net Operating Assets | 96.52% | -208.77% | 557.42% | 10.79% | -2,055.06% |
| Cash from Operations | 15.26% | -12.79% | -2.08% | -11.13% | -35.35% |
| Capital Expenditure | 54.25% | 13.13% | -107.07% | -131.19% | -50.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 117.24% | -139.11% | 2,728.45% | -71.18% | 438.05% |
| Cash from Investing | 114.78% | -141.46% | 3,600.17% | -77.68% | 406.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -30.00% | -50.83% | 54.45% | 23.33% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 80.65% | 84.42% | 33.44% |
| Cash from Financing | -30.00% | -50.81% | 55.07% | 27.36% | 1,877.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.07% | -154.64% | 2,088.94% | -197.25% | 140.81% |